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The objective of these experiments was to explore the possibility of prevent-
ing the rapid destruction and removal from circulation of human erythro-
cytes transfused into rats. Significant prolongation of heterologous erythro-
cyte survival could pave the way for development of a system that might be
useful in studies of blood preservation. There also is the possibility that
certain aspects of these studies could provide the basis for modification of
complement dependent hemolytic disorders in man.
Erythrocytes in heterologous serum in vitro may undergo rapid lysis due
to the presence of complement-binding "natural" antibodies in serum.' The
lytic process probably involves sequential activation of all nine components
of complement.' The extremely short intravascular survival of heterologous
erythrocytes is the result not only of hemolysis due to complement-binding
antibody but also of the rapid removal of the sensitized erythrocytes by the
cells of the reticuloendothelial system (RES), especially those of the liver
and spleen.'
In order to prolong the survival of human erythrocytes in the rat, the
third component of complement, C3, which is essential for hemolysis, was
inhibited through the administration of a cobra venom factor (CVF).' This
factor also is a striking inhibitor of phagocytosis,' but has no effect on ag-
glutination of red cells by immune or "natural" antibody. Further improve-
ment in erythrocyte survival was achieved when CVF was combined with
either surgical splenectomy or pretreatment with ethyl plamitate (EP)
which both blocks the RES and produces functional splenic ablation (medi-
cal splenectomy), but has no known effect on hemolytic complement.'
MATERIALS AND METHODS
The CVF from venom of Naja naja was isolated as a non-toxic 6.6 S
protein by chromatographic techniques already described for a similar, if not
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identical, protein in venom ofNaja haje.' In brief, crude venom was applied
to DEAE cellulose, pH 7.5, at low ionic strength. One major toxin, a he-
molysin, and CVF wereabsorbed, while two other major toxins passed into
the effluent. Upon elution of the DEAE column, the hemolysin separated
when the salt concentration reached 0.02 ionic strength while the anticom-
plementary factor did not appear until ionic strength 0.12 was attained.
Further purification to give a preparation showing only one band on disc
electrophoresis was achieved by chromatography, first on CM-cellulose, pH
5, and then by passage through Sephadex G-200. The CVF eluted from the
CM column when the salt concentration was raised to about 0.10 ionic
strength. This protein was non-toxic when large doses were injected into
mice, did not lyse erythrocytes in the presence of lecithin, did not kill sev-
eral types of cells in tissue cultures, but was strongly anticomplementary at
high dilutions when mixed with either guinea pig or human serum. The
final preparation contained about 0.12 mg. protein per ml.
Approximately 15 ml. of whole human blood (ACD anticoagulated Group
0, D positive) was incubated for 30 minutes at room temperature with ap-
proximately 300 uc of 51Cr (sodium chromate). The red cells then were
washed twice with saline and the hematocrit was adjusted to about 277o.
Recipient animals were male Sprague Dawley rats weighing from 150 to
250 g. These were divided into six groups (4 to 15 animals in each group)
as follows: Group 1-untreated controls, Group 2-surgical splenectomy 5
to 7 days prior to transfusion, Group 3-intravenous injection of 1 mnL of
CVF (0.12 mg/ml.) from 1 to 10 minutes prior to transfusion, Group 4-
single intravenous injection of EP (3 g/kg.) 48 hours prior to transfusion,
Group 5-surgically splenectomized rats given 1 ml. of CVF from 1 to 10
minutes prior to transfusion, and Group 6-pretreated with both EP (same
as Group 4) and CVF (same as Group 3) prior to transfusion. The trans-
fusions consisted of 0.1 ml. of the 51Cr tagged human blood per 35 grams of
body weight per rat administered through the dorsal vein of the penis.
Blood samples from the tail for radioassay were collected at intervals rang-
ing from 2 to 30 min. in 20 Pul glass pipettes. These samples then were
counted in a well-type scintillation counter with the counting error for each
sample at less than 2%lo. Sample counts usually ranged from 3 to 10 times
background. Net counts were calculated as percent of the 2 minute post-
injection samnple. 51Cr human erythrocyte T 2 survival in minutes was de-
termined from the 507% intercept of the best straight line plot through all
points on semilog paper.
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RESULTS
The mean erythrocyte T Y/ survival for groups 1 and 2 were 6.5 and 6.4
minutes, respectively, without significant differences between the groups
(Table 1). Mean erythrocyte T Y/ survival was significantly improved
over the control group to 52 minutes in the Group 3 rats which had received
only a single injection of CVF. Human erythrocyte survival in Group 4
(EP) and Group 5 (splenectomy and CVF) rats was greatly prolonged to
significant T Y2 values of 133 and 149 min., respectively. Improvement was
greatest in Group 6 (EP and CVF) rats where the mean erytlirocyte T Y2
was 292 min. This represents an increase in mean erythrocyte T 52 survival
over controls by a factor of about 45. The best erythrocyte T 52 survival
was 380 minutes which is about a 60-fold improvement in heterologous
erythrocyte T Y2 survival.
DISCUSSION
These observations demonstrate the effectiveness of the sequential block-
ing of certain factors responsible for the in vivo destruction of incompatible
heterologous erythrocytes. The precise mechanisms through which erythro-
cyte survival is prolonged is uncertain, but information concerning the tissue
effects of EP and CVF provides the basis for some reasonable speculation.
Presumably, the combination of intravascular hemolysis and RES removal
of heavily damaged erythrocytes was of such magnitude that splenectomy
alone had no effect. CVF-induced reduction in erythrocyte surface damage
and intravascular hemolysis, however, resulted in -significant improvement
in erythrocyte survival. EP alone induced sufficient RES blockade and
TABLE 1. T Y2 SURVIVAL OF HUMAN R CELs IN RATS
Mean T M
Group Experimental Humanredcell TX/ (min.)
nO. comditions (min.) in each rat forgroup ± SD P
1 Control 13, 4, 7, 8, 8, 3, 6, 5
4,6,8,7,6,6,7 6.5 2.6
2 Splenectomy 7, 6, 4, 8, 4, 7, 10 6.4 2.2 >.5
3 CVF' 50, 55,42, 59 51.5 7.3 <.05
4 EP** 222, 122, 108, 118, 94 132.8 51 <.01
5 Splenectomy 45, 250, 60, 230, 130
and CVF 126, 200 148.7 86 <.01
6 EP and CVF 350, 224, 380, 288, 216 291.6 55 <.001
* The cobra venom factor (CVT) administered was .12 mg/rat
**The dose of ethyl palhnitate (EP) was 3 gm/kg.
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splenic ablation to moderately impede the removal of erythrocytes that were
heavily damaged through complement antibody binding. The favorable ef-
fect of splenectomy when combined with CVF probably represented the
elimination of preferential splenic trapping of protein-coated erythrocytes
that were only slightly damaged.' The combination of RES blockade, splenic
destruction and C3 inactivation through the use of EP and CVF produced
the best results [Group 6 mean erythrocyte T Y2 survival was significantly
better than the mean for Group 5 (P - .01).]
It seems likely that future results will be improved through use of multiple
blocking agents combined with techniques designed to inhibit agglutination
and phagocytosis in animals with greater erythrocyte compatibility and
more complete suppression of C3 or other components of complement that
are essential for hemolysis. The C3 activity of guinea pigs is depressed for
periods of from 3 to 5 days following a single injection of CVF.8 The pos-
sibility of developing a practical system that might permit survival of either
heterologous or incompatible homologous erythrocytes for periods of several
days or more does not seem unreasonable. Inhibition of autoimmune hemo-
lytic mechanisms with CVF is an additional area of considerable promise.
SUMMARY
A fortyfold enchancement of human erythrocyte T Y2 survival in the rat
was achieved through the combination of RES blockade, chemically induced
splenic ablation and inactivation of the third component of complement fol-
lowing injection of ethyl palmitate and a factor isolated from cobra venom.
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